DermaSensor key facts
as of Oct 2026- Developer of a skin cancer evaluation technology designed to provide spectroscopy and machine learning technologies to detect skin cancer early.
- DermaSensor is valued at approximately $66.8M as of Oct 2026, set at its later-stage round, Dec 2024; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $66.7M across 2 recorded rounds; the latest was Early Stage VC ($8.9M) in Nov 2024.
- Notable investors include MedTech Innovator, Texas Medical Center, Ligo Partners, Lateral Capital Management, Miami Angels — 19 tracked in total.
- 1 investment vehicle was formed to buy DermaSensor shares in the last 12 months, reporting $55K sold to 4 investors, per SEC Form D filings.
- DermaSensor has filed 2 Form Ds with the SEC since 2020, most recently Dec 2024 ($8.9M sold to 41 investors).
- Status: Privately Held (backing).
Valued at $66.8M at its later-stage round, Dec 2024. Nothing has traded since.
- ·The complete investor list: 19 names
- ·Watch DermaSensor: the Monday email on marks, rounds and moves
DermaSensor funding rounds
2 roundsVehicles formed to buy DermaSensor shares
secondary demand · SEC Form D filingsIn the last 12 months, 1 investment vehicle were formed to buy DermaSensor shares, reporting $55K sold to 4 investors. Most recent filing Mar 2026.
Membership and data by Private Market View
Who backs DermaSensor
19+DermaSensor valuation
DermaSensor was valued at $66.8 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has DermaSensor raised?
DermaSensor has raised $66.7 million in total; 2 of its rounds are on record. The largest on record was an $8.9 million early-stage round in Nov 2024.
DermaSensor has filed 2 Form Ds with the SEC since 2020, most recently in Dec 2024 ($8.9 million sold to 41 investors).
Institutional holders and vehicles
In the last 12 months, 1 investment vehicle was formed to buy DermaSensor shares, reporting $55,000 sold to 4 investors, per SEC Form D filings (most recent Mar 2026).
DermaSensor investors
19 investors are on record for DermaSensor, including MedTech Innovator, Texas Medical Center, Ligo Partners and Lateral Capital Management. By type, the record holds 5 venture capital firms, 2 family offices and 1 angel investor. The early-stage round in Nov 2024 drew 41 investors.
About DermaSensor
Developer of a skin cancer evaluation technology designed to provide spectroscopy and machine learning technologies to detect skin cancer early. The company's technology utilizes elastic scattering spectroscopy technology and machine learning algorithms to track and differentiate cancerous skin and send alerts and notifications when such cells are detected, enabling patients to efficiently check for skin cancer at home and clinics without waiting for time-consuming diagnostic reports.
- Sector
- Healthcare
- HQ
- Miami, FL, United States
- Founded
- 2009
- Employees
- 31
- Website
- dermasensor.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.